acemachine learning models based on multimodal big data for precision transfusion management in acute myeloid leukaemia
Source article: Research and application of machine learning models based on multimodal big data for precise transfusion management in acute myeloid leukaemia
Acute myeloid leukaemia (AML) is a highly heterogeneous haematologic malignancy in which transfusion support represents an essential component of comprehensive patient care. This review aims to provide an updated synthesis of recent progress in the development and clinical application of machine learning models based on multimodal big data for precision transfusion management in AML, addressing the persistent limitations of conventional, empirically guided transfusion practices. We systematically reviewed the li…
Positive state: both sides are scored from claims and sources, not community votes.
United States Naval Medical Bulletin Vol. 9, Nos. 1-4, 1915 by U.S. Navy. Bureau of Medicine and Surgery. Public domain
This peer-reviewed review published July 24, 2026 synthesized recent progress on machine learning models that integrate multimodal big data such as electronic health records, genomic and proteomic data to guide transfusion support for acute myeloid leukaemia, a highly heterogeneous malignancy where transfusion is essential.
The synthesis matters because it moves transfusion practice from empirically guided approaches toward individualized prediction of demand and risk, but the source itself flags that privacy protection, data standardisation, and interpretability remain unresolved for clinical adoption, with federated learning and explainable AI proposed as next steps.
- Review focused on multimodal data integration including electronic health records, genomic, proteomic and other high-dimensional datasets for AML transfusion management.
- Analysed algorithms included decision trees, random forests and neural networks applied to transfusion demand prediction and reaction risk assessment.
- Representative clinical case studies were cited as demonstrating practical utility of the models.
- Authors identified future directions involving federated learning and explainable artificial intelligence to address current limitations.
Machine learning models integrating multimodal big data improved precision transfusion management for AML patients by predicting transfusion demand and assessing transfusion reaction risks.
Deployment of multimodal machine learning for AML transfusion management is limited by data privacy protection, data standardisation across platforms, and model interpretability for clinical adoption.
The rundown
The review systematically examined literature on integrating electronic health records, genomic, proteomic and other high-dimensional datasets, and analysed decision trees, random forests and neural networks for transfusion demand prediction and reaction risk assessment in AML.
While case studies were reported to support practical utility and improved transfusion safety and clinical outcomes, the authors noted persistent barriers around privacy, standardisation, and interpretability, pointing to federated learning and explainable AI as future directions.
Clinical adoption is constrained by unresolved issues of data privacy protection, cross-platform data standardisation, and model interpretability.
Sources
- Peer-reviewedTransfusion Medicine2026-07-24
How should this claim be treated?
The debate